Trinity Biotech (TRIB) Receivables Refunds (2016 - 2024)
Trinity Biotech (TRIB) has disclosed Receivables Refunds for 9 consecutive years, with $518000.0 as the latest value for Q4 2024.
- Quarterly Receivables Refunds fell 65.83% to $518000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $518000.0 through Dec 2024, down 65.83% year-over-year, with the annual reading at $518000.0 for FY2024, 65.83% down from the prior year.
- Receivables Refunds hit $518000.0 in Q4 2024 for Trinity Biotech, down from $1.5 million in the prior quarter.
- In the past five years, Receivables Refunds ranged from a high of $3.1 million in Q4 2020 to a low of $518000.0 in Q4 2024.
- Historically, Receivables Refunds has averaged $1.7 million across 5 years, with a median of $1.5 million in 2021.
- Biggest five-year swings in Receivables Refunds: soared 55.7% in 2020 and later plummeted 65.83% in 2024.
- Year by year, Receivables Refunds stood at $3.1 million in 2020, then crashed by 50.13% to $1.5 million in 2021, then grew by 19.17% to $1.8 million in 2022, then dropped by 17.34% to $1.5 million in 2023, then tumbled by 65.83% to $518000.0 in 2024.
- Business Quant data shows Receivables Refunds for TRIB at $518000.0 in Q4 2024, $1.5 million in Q4 2023, and $1.8 million in Q4 2022.